Clinical Trials on Thyroid Carcinoma, Medullary in Japan
Total 784 results
-
Genzyme, a Sanofi CompanyCompletedUnresectable Locally Advanced or Metastatic, Medullary Thyroid CarcinomaJapan
-
BayerCompletedThyroid CarcinomaJapan
-
BayerActive, not recruiting
-
Loxo Oncology, Inc.Eli Lilly and CompanyActive, not recruitingMedullary Thyroid CancerUnited States, Canada, Spain, China, Taiwan, Australia, Japan, India, Belgium, Germany, France, Netherlands, Czechia, Brazil, Korea, Republic of, United Kingdom, Italy, Israel, Greece, Poland, Russian Federation
-
National Cancer Center Hospital EastOno Pharmaceutical Co. LtdActive, not recruitingAnaplastic Thyroid CancerJapan
-
Osaka UniversityRecruitingThyroid CancerJapan
-
Loxo Oncology, Inc.Eli Lilly and CompanyRecruitingSoft Tissue Sarcoma | Medullary Thyroid Cancer | Papillary Thyroid Cancer | Infantile Fibrosarcoma | Infantile MyofibromatosisUnited States, Australia, Japan, Canada, Germany, Korea, Republic of, France, Spain, United Kingdom, Denmark, Italy
-
Loxo Oncology, Inc.Eli Lilly and CompanyAvailableBreast Cancer | Pancreatic Cancer | Non Small Cell Lung Cancer | Colon Cancer | Medullary Thyroid Cancer | Papillary Thyroid Cancer | Other Solid Tumors With Evidence of Activating RET AlterationSpain, United States, Australia, France, Germany, Israel, Italy, Japan, New Zealand, Poland, Singapore, Switzerland
-
Translational Research Center for Medical Innovation...CompletedAnaplastic Thyroid CancerJapan
-
Eisai Co., Ltd.Completed
-
Ito HospitalCompletedThyroid Disease | Parathyroid DiseaseJapan
-
Eisai Co., Ltd.Completed
-
Loxo Oncology, Inc.Eli Lilly and CompanyRecruitingNon-Small Cell Lung Cancer | Colon Cancer | Medullary Thyroid Cancer | Any Solid TumorUnited States, Japan, Taiwan, Australia, Korea, Republic of, Israel, Spain, Switzerland, Singapore, France, Canada, Italy, Germany, United Kingdom, Hong Kong, Denmark
-
AstraZenecaCompletedStomach Neoplasms | Small Cell Lung Carcinoma | Ovarian Neoplasms | Fallopian Tube Neoplasms | Peritoneal Neoplasms | Triple Negative Breast Neoplasms | Esophageal Squamous Cell Carcinoma | Carcinoma, Pancreatic Ductal | Carcinoma, Squamous Cell of Head and Neck | Esophagogastric Junction NeoplasmsKorea, Republic of, Japan
-
National Cancer Center, JapanMerck Sharp & Dohme LLCRecruitingUntreated Advanced or Recurrent Thymic CarcinomasJapan
-
Niigata University Medical & Dental HospitalMerck Sharp & Dohme LLCRecruitingOvarian Squamous Cell CarcinomaJapan
-
Nihon Pharmaceutical Co., LtdRecruitingAutoimmune EncephalitisJapan
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdNot yet recruitingMuscle-invasive Urothelial CarcinomaJapan
-
Genzyme, a Sanofi CompanyCompletedEvaluation of Efficacy, Safety of Vandetanib in Patients With Differentiated Thyroid Cancer (VERIFY)Differentiated Thyroid CancerUnited States, Sweden, Brazil, Italy, Poland, Spain, China, Russian Federation, France, Japan, Denmark, Czechia
-
Zeria PharmaceuticalCompletedAdvanced Hepatocellular CarcinomaJapan
-
National Cancer Center, JapanOno Pharmaceutical Co. Ltd; Fiverings Co., Ltd.Active, not recruitingLocally Advanced Esophageal Squamous Cell CarcinomaJapan
-
Translational Research Center for Medical Innovation...Okayama University; Japanese Gynecologic Oncology Group (JGOG)RecruitingFallopian Tube Carcinoma | Peritoneal Carcinoma | Ovarian Carcinoma | BRCA1 and/or BRCA2 Variant CarriersJapan
-
Yamagata UniversityUnknownMetastatic Renal Cell CarcinomaJapan
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdActive, not recruitingAdvanced or Metastatic Renal Cell CarcinomaJapan
-
Kyowa Kirin Co., Ltd.Completed
-
BayerCompletedThyroid NeoplasmsUnited States, Japan, Turkey, Russian Federation, India, Germany, France, Mexico, Philippines, Greece, Netherlands, Spain, Taiwan, Brazil, Egypt, Argentina, Algeria, Lebanon, Saudi Arabia
-
Hokkaido University HospitalMerck Sharp & Dohme LLCRecruiting
-
Fukushima Medical UniversityHuman Genome Center, Institute of Medical Science, University of TokyoUnknownHepatocellular CarcinomaJapan
-
Kansai Hepatobiliary Oncology GroupUnknownHepatocellular CarcinomaJapan
-
Keio UniversityRecruitingEsophageal Squamous Cell CarcinomaJapan
-
National Cancer Center, JapanRecruitingEsophageal Squamous Cell CarcinomaJapan
-
Kyowa Kirin Co., Ltd.Completed
-
AstraZenecaCompletedCarcinoma | Cancer | TumorsJapan
-
Eisai Co., Ltd.CompletedHepatocellular CarcinomaJapan
-
Sumitomo Pharma Co., Ltd.CompletedHepatocellular CarcinomaJapan
-
Otsuka Pharmaceutical Co., Ltd.CompletedHepatocellular CarcinomaJapan
-
PfizerCompleted
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompleted
-
Sumitomo Pharma Co., Ltd.CompletedHepatocellular Carcinoma | Advanced Solid TumorsJapan
-
Bristol-Myers SquibbCompletedKidney Cancer | Renal Cell CarcinomaJapan
-
Kindai UniversityUnknownCarcinoma, Hepatocellular | Hepatocellular Carcinoma | Liver Neoplasm | Unresectable Hepatocellular CarcinomaJapan
-
Merck KGaA, Darmstadt, GermanyCompleted
-
Southern Tohoku BNCT Research CenterActive, not recruitingHead and Neck Cancer | Squamous Cell CarcinomaJapan
-
BayerRegeneron PharmaceuticalsCompletedChoroidal NeovascularizationJapan
-
Eisai Inc.CompletedThyroid CancerUnited States, Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, Czechia, Denmark, France, Germany, Italy, Japan, Korea, Republic of, Poland, Portugal, Romania, Russian Federation, Spain, Sweden, Thailand, United Kingdom
-
BayerCompleted
-
BayerAmgenCompletedThyroid NeoplasmsFrance, China, Korea, Republic of, United States, Spain, Russian Federation, United Kingdom, Netherlands, Sweden, Austria, Italy, Bulgaria, Poland, Saudi Arabia, Germany, Japan, Belgium, Denmark
-
Eisai Co., Ltd.Completed
-
Telix International Pty LtdCompletedCarcinoma, Renal Cell | Clear Cell Renal Cell CarcinomaJapan
-
TakedaActive, not recruitingHepatocellular CancerJapan